Inhibitors of cathepsin S

Details for Australian Patent Application No. 2004279331 (hide)

Owner IRM LLC

Inventors He, Yun; Bursulaya, Badry; Tully, David C.; Chatterjee, Arnab; Woodmansee, David; Karanewsky, Donald S.; Guo, Jianhua; Liu, Hong; Alper, Phillip B.; Mutnick, Daniel

Agent Davies Collison Cave

Pub. Number AU-B-2004279331

PCT Pub. Number WO2005/034848

Priority 10/922,515 18.08.04 US; 60/496,980 20.08.03 US

Filing date 19 August 2004

Wipo publication date 21 April 2005

Acceptance publication date 30 August 2007

International Classifications

C07D 209/04 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/401 (2006.01) - Proline

A61K 31/404 (2006.01)

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/454 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/537 (2006.01) - spiro-condensed or forming part of bridged ring systems

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 295/13 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 411/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/034848 Priority application(s): WO2005/034848

30 August 2007 Application Accepted

  Published as AU-B-2004279331

10 January 2008 Standard Patent Sealed

17 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004279332-Nonsedating alpha-2 agonist 1- (2, 3-dimethyl-phenyl) -ethyl-1, 3-dihydro-imizadole-2-thione

2004279329-Methods of reducing risk of infection from pathogens